ReCor Medical Names Lara Barghout President and Chief Executive Officer
January 3, 2023
Ms. Barghout brings more than 20 years of experience leading global businesses in the medical device industry.
Our Blog
Category: News
ReCor Medical and Otsuka Medical Devices Announce Submission of Application for Pre-Market Approval of the Paradise™ Ultrasound Renal Denervation (uRDN) System to the U.S. Food and Drug Administration
November 30, 2022
The Paradise uRDN System is designed to reduce sympathetic nerve activity by denervating nerves which surround the renal arteries with the goal of reducing blood pressure.
ReCor Medical Announces Consistent Reduction of Blood Pressure in Pooled Analysis of Three Clinical Trials at AHA 2022
November 6, 2022
The results come from analysis of the pooled data from ReCor’s RADIANCE Global Clinical Trial Program.